277 related articles for article (PubMed ID: 29181869)
1. Sample size re-estimation incorporating prior information on a nuisance parameter.
Mütze T; Schmidli H; Friede T
Pharm Stat; 2018 Mar; 17(2):126-143. PubMed ID: 29181869
[TBL] [Abstract][Full Text] [Related]
2. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
Mütze T; Friede T
Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
[TBL] [Abstract][Full Text] [Related]
3. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
4. Sample size reestimation and Bayesian predictive probability for single-arm clinical trials with a time-to-event endpoint using Weibull distribution with unknown shape parameter.
Waleed M; He J; Phadnis MA
J Biopharm Stat; 2024 Jul; 34(4):469-487. PubMed ID: 37545144
[TBL] [Abstract][Full Text] [Related]
5. Two-stage sample size re-estimation based on a nuisance parameter: a review.
Proschan MA
J Biopharm Stat; 2005; 15(4):559-74. PubMed ID: 16022163
[TBL] [Abstract][Full Text] [Related]
6. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
Wu PS; Lin M; Chow SC
J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
[TBL] [Abstract][Full Text] [Related]
7. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
Friede T; Kieser M
Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
[TBL] [Abstract][Full Text] [Related]
8. Sample size determination and re-estimation for matched pair designs with multiple binary endpoints.
Xu J; Yu M
Biom J; 2013 May; 55(3):430-43. PubMed ID: 23553605
[TBL] [Abstract][Full Text] [Related]
9. Bayesian sample size re-estimation using power priors.
Brakenhoff TB; Roes K; Nikolakopoulos S
Stat Methods Med Res; 2019 Jun; 28(6):1664-1675. PubMed ID: 29717945
[TBL] [Abstract][Full Text] [Related]
10. Blinded sample size re-estimation for recurrent event data with time trends.
Schneider S; Schmidli H; Friede T
Stat Med; 2013 Dec; 32(30):5448-57. PubMed ID: 24105855
[TBL] [Abstract][Full Text] [Related]
11. Re-calculating the sample size in internal pilot study designs with control of the type I error rate.
Kieser M; Friede T
Stat Med; 2000 Apr; 19(7):901-11. PubMed ID: 10750058
[TBL] [Abstract][Full Text] [Related]
12. Sample size re-estimation for survival data in clinical trials with an adaptive design.
Togo K; Iwasaki M
Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
[TBL] [Abstract][Full Text] [Related]
13. On the inappropriateness of an EM algorithm based procedure for blinded sample size re-estimation.
Friede T; Kieser M
Stat Med; 2002 Jan; 21(2):165-76. PubMed ID: 11782057
[TBL] [Abstract][Full Text] [Related]
14. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
Schneider S; Schmidli H; Friede T
Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
[TBL] [Abstract][Full Text] [Related]
15. Modified power prior with multiple historical trials for binary endpoints.
Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
[TBL] [Abstract][Full Text] [Related]
16. Sample size re-estimation in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD
Stat Methods Med Res; 2019 Jun; 28(6):1852-1878. PubMed ID: 29869564
[TBL] [Abstract][Full Text] [Related]
17. Variance estimation in clinical studies with interim sample size re-estimation.
Miller F
Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
[TBL] [Abstract][Full Text] [Related]
18. Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends.
Asendorf T; Henderson R; Schmidli H; Friede T
Stat Med; 2019 Apr; 38(9):1503-1528. PubMed ID: 30575061
[TBL] [Abstract][Full Text] [Related]
19. Sample size re-estimation for adaptive sequential design in clinical trials.
Gao P; Ware JH; Mehta C
J Biopharm Stat; 2008; 18(6):1184-96. PubMed ID: 18991116
[TBL] [Abstract][Full Text] [Related]
20. Addressing prior-data conflict with empirical meta-analytic-predictive priors in clinical studies with historical information.
Li JX; Chen WC; Scott JA
J Biopharm Stat; 2016; 26(6):1056-1066. PubMed ID: 27541990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
